Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,456 public trials 324 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501

Conditions
Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations
  • Altana Pharma/Nycomed Encinitas, California, United States
  • Altana Pharma/Nycomed Huntington Beach, California, United States
  • Altana Pharma/Nycomed Long Beach, California, United States
  • Altana Pharma/Nycomed Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

NCT00305487

Conditions
Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +9 more
Locations
  • Altana Pharma/Nycomed Birmingham, Alabama, United States
  • Altana Pharma/Nycomed Hot Springs, Arkansas, United States
  • Altana Pharma/Nycomed Costa Mesa, California, United States
  • Altana Pharma/Nycomed Huntington Beach, California, United States
View all 71 locations
View Trial Details
Completed

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

NCT00163436

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed La Malbaie, Quebec, Canada
  • Altana Pharma/Nycomed London, Canada
  • Altana Pharma/Nycomed London,ON, Canada
  • Altana Pharma/Nycomed Mississauga, Canada
View all 66 locations
View Trial Details
Completed

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

NCT00163358

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Adelaide South Australia, Australia
  • Altana Pharma/Nycomed Auchenflower, Australia
  • Altana Pharma/Nycomed Bracken Ridge, Australia
  • Altana Pharma/Nycomed Burwood, Australia
View all 111 locations
View Trial Details
Completed

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

NCT01537133

Conditions
Asthma, Atopy, Bronchial Diseases, +7 more
Locations
  • University of California, San Francisco, Adult San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions